Clinical Features	Time to Death		AGE		GENDER		HISTOLOGICAL.TYPE		NEOADJUVANT.THERAPY	
	nCNV (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q
1q gain	5 (3%)	161	0.85513	1	0.19265	1	0.62243	1	0.32262	1	1	1
4p gain	3 (2%)	163	0.00014016	0.0193	0.12229	1	1	1	0.7559	1	1	1
4q gain	3 (2%)	163	0.00014016	0.0193	0.12229	1	1	1	0.7559	1	1	1
5p gain	6 (4%)	160	0.0093748	1	0.084562	1	1	1	0.33884	1	1	1
5q gain	6 (4%)	160	0.0093748	1	0.084562	1	1	1	0.33884	1	1	1
7p gain	6 (4%)	160	0.74342	1	0.11065	1	1	1	0.33884	1	1	1
7q gain	8 (5%)	158	0.74342	1	0.059602	1	0.4429	1	0.117	1	1	1
12p gain	6 (4%)	160	0.74342	1	0.40278	1	1	1	0.33884	1	1	1
12q gain	6 (4%)	160	0.74342	1	0.40278	1	1	1	0.33884	1	1	1
14q gain	3 (2%)	163	0.79285	1	0.62881	1	0.55923	1	0.7559	1	1	1
16p gain	6 (4%)	160	0.79285	1	0.56768	1	0.18533	1	0.59478	1	1	1
16q gain	4 (2%)	162	0.79285	1	0.40196	1	0.57816	1	0.83227	1	1	1
17p gain	6 (4%)	160	0.74342	1	0.55548	1	0.18533	1	0.73606	1	1	1
17q gain	7 (4%)	159	0.74342	1	0.77254	1	0.19294	1	0.8481	1	1	1
20p gain	4 (2%)	162	0.74342	1	0.43039	1	0.57816	1	0.2516	1	1	1
20q gain	3 (2%)	163	0.74342	1	0.60008	1	0.55923	1	0.7559	1	1	1
2p loss	5 (3%)	161	1	1	0.4051	1	1	1	0.58133	1	1	1
2q loss	4 (2%)	162	1	1	0.092842	1	1	1	0.30685	1	1	1
9q loss	4 (2%)	162	1	1	0.080026	1	1	1	0.50209	1	1	1
10q loss	3 (2%)	163	0.85513	1	0.38829	1	0.19348	1	0.12862	1	1	1
11p loss	3 (2%)	163	4.3205e-08	6.05e-06	0.10202	1	0.19348	1	0.7559	1	1	1
11q loss	4 (2%)	162	4.3205e-08	6.05e-06	0.059159	1	0.069095	1	0.30685	1	1	1
13q loss	7 (4%)	159	0.0022502	0.306	0.51716	1	0.40532	1	0.1682	1	1	1
17p loss	3 (2%)	163	0.79285	1	0.87142	1	0.55923	1	0.7559	1	1	1
18p loss	3 (2%)	163	1	1	0.92666	1	0.55923	1	1	1	1	1
18q loss	3 (2%)	163	1	1	0.92666	1	0.55923	1	1	1	1	1
21q loss	3 (2%)	163	1	1	0.027789	1	0.19348	1	1	1	1	1
22q loss	25 (15%)	141	0.85513	1	0.94854	1	1	1	0.29292	1	1	1